Previous Close | 0.7600 |
Open | 1.1100 |
Bid | 0.0000 |
Ask | 1.5000 |
Strike | 300.00 |
Expire Date | 2024-05-17 |
Day's Range | 0.7600 - 1.1100 |
Contract Range | N/A |
Volume | |
Open Interest | 4 |
WAYNE, Pa., May 07, 2024 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a global leader in medical technologies, today announced the presentation of new research findings from the 2024 American Urological Association Annual Meeting in San Antonio, TX, May 3 – 6, 2024, showcasing excellent patient experience* with the Prostatic Urethral Lift (PUL) with the UroLift™ System for benign prostatic hyperplasia (BPH). This year’s research marks the first time results from two randomized head-to-
Evaluate Teleflex's (TFX) reliance on international revenue to better understand the company's financial stability, growth prospects and potential stock price performance.
WAYNE, Pa., May 06, 2024 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX) announced today that its Board of Directors declared a quarterly cash dividend of thirty-four cents ($0.34) per share of common stock. The dividend is payable June 14, 2024, to shareholders of record at the close of business on May 15, 2024. Additional information about Teleflex can be obtained from the company’s website at teleflex.com. About Teleflex Incorporated Teleflex is a global provider of medical technologies